Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 164,938 | 72,883 | 264,530 | 203,438 | 147,213 |
| Depreciation Amortization | 9,474 | 4,772 | 12,916 | 9,561 | 6,338 |
| Income taxes - deferred | -2,564 | -1,012 | -999 | -663 | -548 |
| Accounts receivable | N/A | -11,350 | N/A | -534 | 366 |
| Accounts payable and accrued liabilities | 54 | 123 | -787 | 395 | -959 |
| Other Working Capital | 12,939 | -3,130 | -13,178 | -4,336 | 9,351 |
| Other Operating Activity | -38,688 | 5,855 | 7,263 | 674 | 948 |
| Operating Cash Flow | $146,153 | $68,141 | $269,745 | $208,535 | $162,709 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -148,708 | N/A | N/A |
| PPE Investments | -39 | N/A | -2 | -2 | -2 |
| Purchase Of Investment | N/A | N/A | -9,875 | -9,875 | -6,375 |
| Sale Of Investment | N/A | N/A | 43,780 | 42,098 | 16,405 |
| Purchase Sale Intangibles | 33,951 | 23,638 | -241,314 | N/A | N/A |
| Other Investing Activity | -181,049 | -26,362 | -182,035 | 10,571 | -10,525 |
| Investing Cash Flow | $-181,088 | $-26,362 | $-296,840 | $42,792 | $-497 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 74,169 | N/A | N/A |
| Debt Issued | 300,000 | 300,000 | N/A | N/A | N/A |
| Debt Repayment | -29,906 | -29,906 | N/A | N/A | N/A |
| Common Stock Issued | 11,427 | N/A | N/A | N/A | N/A |
| Dividend Paid | -48,088 | -24,042 | -84,006 | -62,943 | -41,964 |
| Other Financing Activity | -78,275 | -48,098 | 22 | 0 | 13 |
| Financing Cash Flow | $155,158 | $197,954 | $-9,815 | $-62,943 | $-41,951 |
| Beginning Cash Position | 94,302 | 94,302 | 131,212 | 131,212 | 131,212 |
| End Cash Position | 214,525 | 334,035 | 94,302 | 319,596 | 251,473 |
| Net Cash Flow | $120,223 | $239,733 | $-36,910 | $188,384 | $120,261 |
| Free Cash Flow | |||||
| Operating Cash Flow | 146,153 | 68,141 | 269,745 | 208,535 | 162,709 |
| Capital Expenditure | -39 | N/A | -2 | -2 | -2 |
| Free Cash Flow | 146,114 | 68,141 | 269,743 | 208,533 | 162,707 |